InvestorsHub Logo
Followers 5
Posts 1272
Boards Moderated 0
Alias Born 03/08/2017

Re: None

Monday, 10/16/2017 11:15:44 PM

Monday, October 16, 2017 11:15:44 PM

Post# of 26907
http://icrowdnewswire.com/2017/06/18/oncoscope-develops-an-optical-biopsy-device-that-helps-physicians-instantly-identify-precancerous-tissues-for-biopsy/

Durham, NC 27701, US
Consumer Products
oncoscope.com

Oncoscope develops an optical biopsy device that helps physicians instantly identify precancerous tissues for biopsy.
Oncoscope, Inc. operates as a medical device company. It develops optical imaging systems for epithelial tissues in the oral cavity, esophagous, stomach, colon, lung, cervix, and bladder. Its systems provide in vivo measurements of the diameter and density of cell nuclei. The company was founded in 2006 and is based in Durham, North Carolina.
Management

Chief Executive Officer
Perry A. Genova


Chief Financial Officer
Tracy T. Jackson


Director
Daniel Pelak
Mr. Pelak has served as a Vertos Medical director since 2008. He is a senior advisor with Welsh, Carson, Anderson & Stowe (WCAS), focusing on investments in the healthcare industry.
Prior to joining WCAS, Mr. Pelak was the chief executive officer at InnerPulse, a privately held, early-stage cardiac medical device company.
Prior to joining InnerPulse, he was the CEO of Closure Medical Corporation, a publically traded biomaterial-based medical adhesive company, until its acquisition by Johnson & Johnson in 2005.
Mr. Pelak began his industry career at Medtronic, where he spent over 20 years. His executive assignments at Medtronic included vice president of U.S. Marketing, and worldwide responsibility for three different operating divisions as vice president and general manager.
Mr. Pelak’s current or recent board positions are InnerPulse, Inc., and AGA Medical Corp., Affinergy, Inc., Mardil, Inc., Oncoscope, Inc.
Mr.


Adam Wax
Founder and Chairman at Oncoscope

twitter: @torenzial L2 UPDATES